Vahri Beaumont is a seasoned professional in the field of pharmacology and neurobiology, currently serving as the Vice President of Preclinical at CHDI Foundation since December 2022. Prior to this role, Vahri held the position of Director of Neurobiology at CHDI Management Inc from April 2007 to December 2022. Experience also includes serving as an Assistant Researcher Step IV at UCLA for a brief tenure in 2006-2007 and as a Senior Research Scientist at Merck Sharp and Dome from April 2003 to March 2006. Vahri Beaumont earned a PhD in Pharmacology from the University of Bristol, followed by postdoctoral studies in synaptic transmission and plasticity at the University of California, Berkeley, and the Laboratory of Molecular Biology, MRC, complemented by a BSc (Hons) in Pharmacology from the University of Bristol.